MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancerShunsuke Kitajima, David A. Barbie, Tetsuo Tani et al.|Cancer Cell|2022Cited by 101
Activation of Tumor-Cell STING Primes NK-Cell TherapyErik H. Knelson, David A. Barbie, Elena V. Ivanova et al.|Cancer Immunology Research|2022Cited by 88
Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast CancerFrancisco Hermida‐Prado, Rinath Jeselsohn, Yingtian Xie et al.|Cancer Research|2023Cited by 15
Data from Activation of Tumor-Cell STING Primes NK-Cell TherapyErik H. Knelson, David A. Barbie, Minyue Chen et al.|Unknown|2023Cited by 1
Supplementary Fig. S4 from Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast CancerFrancisco Hermida‐Prado, Rinath Jeselsohn, Yingtian Xie et al.|Unknown|2023Cited by 0